🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/02/2006 | 47,35 | 47,91 | 46,79 | 47,46 | +0,24% | 2,37% | 112.130 |
| 06/02/2006 | 47,35 | 48,10 | 47,35 | 47,35 | -0,39% | 1,58% | 39.968 |
| 03/02/2006 | 47,54 | 48,47 | 47,16 | 47,54 | +0,00% | 2,76% | 35.987 |
| 02/02/2006 | 47,91 | 49,03 | 47,16 | 47,54 | -0,39% | 3,91% | 91.291 |
| 01/02/2006 | 46,41 | 47,72 | 46,41 | 47,72 | +2,82% | 2,82% | 449.802 |
| 31/01/2006 | 44,84 | 46,60 | 44,73 | 46,41 | +3,16% | 4,17% | 246.034 |
| 30/01/2006 | 44,92 | 45,18 | 44,77 | 44,99 | +0,17% | 0,92% | 225.382 |
| 27/01/2006 | 44,54 | 44,92 | 44,28 | 44,92 | +1,27% | 1,43% | 135.667 |
| 26/01/2006 | 43,87 | 44,99 | 43,87 | 44,35 | +0,85% | 2,56% | 168.983 |
| 25/01/2006 | 44,09 | 44,99 | 43,04 | 43,98 | +0,00% | 4,41% | 186.215 |
| 24/01/2006 | 44,73 | 44,92 | 43,61 | 43,98 | -1,67% | 2,93% | 42.640 |
| 23/01/2006 | 45,33 | 45,48 | 44,54 | 44,73 | -1,32% | 2,06% | 32.033 |
| 20/01/2006 | 47,35 | 47,54 | 44,99 | 45,33 | -4,27% | 5,38% | 203.073 |
| 19/01/2006 | 46,23 | 48,28 | 46,04 | 47,35 | +2,85% | 4,86% | 255.598 |
| 18/01/2006 | 43,42 | 46,30 | 43,42 | 46,04 | +4,68% | 6,64% | 57.387 |
| 17/01/2006 | 43,42 | 43,98 | 42,67 | 43,98 | +0,43% | 3,02% | 89.020 |
| 13/01/2006 | 42,67 | 43,98 | 42,67 | 43,79 | +1,74% | 3,07% | 141.224 |
| 12/01/2006 | 44,92 | 45,10 | 42,67 | 43,04 | -4,17% | 5,42% | 129.282 |
| 11/01/2006 | 45,96 | 46,19 | 44,62 | 44,92 | -2,04% | 3,42% | 102.031 |
| 10/01/2006 | 44,35 | 45,93 | 44,35 | 45,85 | +2,94% | 3,54% | 56.265 |
| 09/01/2006 | 43,87 | 44,84 | 43,72 | 44,54 | +1,54% | 2,56% | 38.632 |
| 06/01/2006 | 43,23 | 44,02 | 43,23 | 43,87 | +1,47% | 1,82% | 67.353 |
| 05/01/2006 | 43,04 | 43,68 | 43,04 | 43,23 | -0,09% | 1,48% | 104.355 |
| 04/01/2006 | 42,86 | 43,83 | 42,86 | 43,27 | +0,52% | 2,27% | 87.070 |
| 03/01/2006 | 41,77 | 43,04 | 41,77 | 43,04 | +3,14% | 3,05% | 108.683 |
| 30/12/2005 | 41,17 | 42,00 | 41,17 | 41,73 | +0,90% | 2,00% | 86.989 |
| 29/12/2005 | 41,40 | 41,66 | 41,17 | 41,36 | -0,09% | 1,18% | 23.911 |
| 28/12/2005 | 41,47 | 41,73 | 41,17 | 41,40 | -0,36% | 1,35% | 21.079 |
| 27/12/2005 | 41,14 | 41,81 | 41,14 | 41,55 | -0,54% | 1,64% | 41.170 |
| 23/12/2005 | 41,17 | 41,92 | 41,17 | 41,77 | +0,36% | 1,82% | 14.534 |